Stonebridge Capital Advisors’s Globus Medical GMED Stock Holding History

Stonebridge Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-160	Closed	-$7.94K	–	457
2023 Q3	$7.94K	Buy	160 +60	+60%	+$3.35K	﹤0.01%	638
2023 Q2	$5.95K	Hold	100	–	–	﹤0.01%	694
2023 Q1	$5.66K	Hold	100	–	–	﹤0.01%	698
2022 Q4	$7.43K	Hold	100	–	–	﹤0.01%	647
2022 Q3	$6K	Hold	100	–	–	﹤0.01%	654
2022 Q2	$6K	Hold	100	–	–	﹤0.01%	681
2022 Q1	$7K	Hold	100	–	–	﹤0.01%	721
2021 Q4	$7K	Hold	100	–	–	﹤0.01%	693
2021 Q3	$8K	Sell	100 -100	-50%	-$8.03K	﹤0.01%	648
2021 Q2	$14K	Buy	200 +100	+100%	+$7.11K	﹤0.01%	680
2021 Q1	$6K	Buy	+100	New	+$6.33K	﹤0.01%	710
2020 Q3	–	Sell	-100	Closed	-$5K	–	380
2020 Q2	$5K	Buy	+100	New	+$4.82K	﹤0.01%	562

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stonebridge Capital Advisors's GMED Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 160 shares — an estimated $7.94K sold.

Stonebridge Capital Advisors first reported a position in GMED in Q2 2020 and held it in 12 quarters. The position peaked at $14K in Q2 2021. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 160 Globus Medical shares in Q4 2023, an estimated $7.94K.
Stonebridge Capital Advisors first reported a position in Globus Medical in Q2 2020 and held it in 12 quarters.
Stonebridge Capital Advisors's Globus Medical position peaked at $14K in Q2 2021.
408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.